Harmony Biosciences Holdings (HRMY)
Total asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 714,734 | 548,499 | 419,060 | 255,101 | 134,691 |
| Total assets | US$ in thousands | 999,200 | 811,448 | 673,870 | 433,443 | 427,074 |
| Total asset turnover | 0.72 | 0.68 | 0.62 | 0.59 | 0.32 |
December 31, 2024 calculation
Total asset turnover = Revenue ÷ Total assets
= $714,734K ÷ $999,200K
= 0.72
The total asset turnover ratio for Harmony Biosciences Holdings has shown a positive trend over the past five years, increasing from 0.32 in December 2020 to 0.72 in December 2024. This indicates that the company is generating more revenue relative to its total assets, reflecting improved efficiency in asset utilization. The steady upward movement suggests that Harmony Biosciences Holdings has been able to effectively leverage its assets to drive sales growth and enhance operational performance. Overall, the increasing total asset turnover ratio signals effective management of resources and a potentially strong financial position for the company.
Peer comparison
Dec 31, 2024